Foreign Direct Investment Screening in Europe and the Middle East
One effect of the COVID-19 pandemic has been to accelerate the implementation of new or stricter controls on inward-bound foreign direct investment activity ("FDI"), particularly in the European Union. For example, in March 2020, the European Commission issued revised guidance encouraging EU Member States to make full use of their FDI screening regimes. More recently, the French, Dutch, German, Italian, Spanish and British governments all tightened their respective FDI screening regimes.
These new measures are frequently designed to protect domestic businesses involved in sectors affecting health, medicines, medical equipment, security, public order, and businesses which operate in strategically important sectors and/or which might be vulnerable to foreign takeover as a result of the economic and other consequences of the pandemic.
The consequence is that foreign investors considering FDI will face increased scrutiny and will need to pay close attention to the FDI regimes in countries in which they are seeking to invest. Particularly for multijurisdictional transactions which involve more than one screening regime, it will be important to adopt, and work with legal advisers that are able to manage, a well-coordinated and strategic approach to navigating through those regimes.
This overview describes the main features of the FDI screening regimes at the EU level, and in certain key jurisdictions in Europe and the Middle East.
Jones Day publications should not be construed as legal advice on any specific facts or circumstances. The contents are intended for general information purposes only and may not be quoted or referred to in any other publication or proceeding without the prior written consent of the Firm, to be given or withheld at our discretion. To request reprint permission for any of our publications, please use our “Contact Us” form, which can be found on our website at www.jonesday.com. The mailing of this publication is not intended to create, and receipt of it does not constitute, an attorney-client relationship. The views set forth herein are the personal views of the authors and do not necessarily reflect those of the Firm.